Skip to main content
Clinical Trials/NCT02482909
NCT02482909
Terminated
Not Applicable

A Prospective Randomized Study to Compare the Efficacy of Radiofrequency Ablation and Hepatic Resection as a Primary Treatment for Single Small Hepatocellular Carcinoma

Seoul National University Hospital0 sites68 target enrollmentJuly 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Carcinoma, Hepatocellular
Sponsor
Seoul National University Hospital
Enrollment
68
Primary Endpoint
The patient survival
Status
Terminated
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this prospective randomized study is to compare the efficacy and safety of radiofrequency ablation and hepatic resection for small hepatocellular carcinomas with very homogeneous underlying conditions.

Registry
clinicaltrials.gov
Start Date
July 2005
End Date
July 2013
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kyung-Suk Suh

Professor

Seoul National University Hospital

Eligibility Criteria

Inclusion Criteria

  • Age between 20 and 70 years
  • Child-Pugh class A (score 5-6)
  • Single hepatocellular carcinoma
  • Maximal diameter of the tumor from 2 to 4 cm when measured on MRI or CT (The diameter on MRI was measured prior to that on CT)
  • No previous treatment
  • Platelet count \> 80,000/mm3

Exclusion Criteria

  • HCC abutting main hepatic veins or the first branches of the main portal vein
  • HCC abutting vessels ≥ 0.5 cm

Outcomes

Primary Outcomes

The patient survival

Time Frame: From the intervention up to 5 years or until the death of the participant whichever came first

Secondary Outcomes

  • The disease-free survival(From the intervention up to 5 years or until hepatocellular carcinoma recurrence whichever came first)

Similar Trials